A positive long-term view for Colgate-Palmolive.
Analyst Charles Georgas set his price target for Colgate at $59 (the stock was at $50 at press time), citing the company's "proactive" fourth-quarter restructuring plans and its valuation, among other factors.
"With 75% of worldwide sales outside the U.S., the company is wellestablished in high-growth developing markets," said Mr. Georgas in a note to clients. "We anticipate long-term growth in earnings per share in low double-digits and strong growth in key brands."
Mr. Georgas insisted that the stock's current valuation doesn't reflect Colgate's sustainable growth rate and level of risk.
"Colgate has outperformed the industry, sector, S&P 500 and its chief competitor (P&G), in terms of gross margin, operating margin and net margin based on a five-year average," said Mr. Georgas. "Colgate will continue to expand its margins as the company focuses on more profitable businesses as a result of the recent restructuring."
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||As We Go To Press|
|Publication:||Household & Personal Products Industry|
|Date:||Jan 1, 2005|
|Previous Article:||What's in store for 2005?|
|Next Article:||U.S. demand for I&I chemicals is on the rise: sales projected to exceed $9 billion by 2008.|